Kaival Brands Innovations Group Inc. (KAVL) Releases Q3 Numbers, Revenues up by 44%

 

• Q3 2020 revenue numbers paint a bright future for KAVL with revenue up by approximately 44%
• Company closely focused on expanding distribution into large national retailers, convenience chains during Q4
• Much of Q3 activity centered around Bidi(TM) Sticks

Kaival Brands Innovations Group (OTCQB: KAVL), a company focused on growing and incubating innovative and profitable products into mature, dominant brands, recently released its Q3 financial report. The report showed revenues for KAVL up by approximately 44% compared to Q2 2020. In addition, the report noted that national distribution channels are being established for future growth.

“We had an extremely busy and fruitful third fiscal quarter,” said Kaival Brands president and CEO Niraj Patel. “We experienced a rising demand for our exclusively distributed premium product, the Bidi(TM) Stick. Our sales growth is occurring mostly organically through smaller distribution channels and wholesalers. . . . Now in the fourth fiscal quarter, we are more closely focused on expanding our distribution into large national retailers and convenience chains.”

According to the revenue report, revenues for Q3 were approximately $32.4 million, bringing the total revenues for the year thus far to nearly $54.9 million. Other numbers worth noting include gross profits for Q3 nearing $4.4 million, total cost of revenue – related party was approximately $28 million for the third quarter of fiscal 2020, and total operating expenses during the quarter reaching approximately $1.5 million. Net income for Q3 2020 was an estimated $2.6 million, and the company reported a cash balance of roughly $2.7 million as of July 31, 2020.

Much of the company’s activity centered around Bidi Sticks; Kaival Brands is the exclusive global distributor of the completely self-contained, disposable and recyclable product, designed to revolutionize the vaping experience.

“We are proud to announce that Bidi Sticks can now be found nationally in over 850 retail stores, like Fas Mart and SprintMart, in addition to over 2,200 current Circle K convenience stores,” Patel said. “And we expect in the coming months for our distribution to expand into thousands more retailers and convenience chains.”

Patel also noted that the innovative product is now available on the entire island of Guam, as an initial order valued at approximately $166,000 had been shipped to Ambros Inc. This Guam-based company is the exclusive distributor of SC Johnson and Budweiser products to all retailers located in that country. “The Bidi(TM) Stick will be the only vaping device offered by Ambros Inc. to their customers and retailers,” Patel said.

Made from high-quality components and equipped with a long-lasting battery and class C nicotine, the Bidi Stick is a self-contained, disposable product that is tamperproof and recyclable. Available in 11 flavors, the Bidi(TM) Stick includes sensitivity control system technology, offering a premium vaping experience for adult consumers only.

Kaival Brands is focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. Kaival’s vision is to develop internally, acquire, own or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation.

For more information, visit the company’s website at www.KaivalBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

Pure Extract Poised to Benefit as Mainstream Society Embraces Functional Mushrooms

 

• Following $1.25 million donation, UC Berkeley launching Center for the Science of Psychedelics
• Pure Extract Technologies Inc. expanding into functional and medicinal mushroom market
• Psychedelic compounds increasingly being studied to treat wide range of physical, mental conditions
• Pure Extracts plans to obtain a Natural Health Products Site License from Health Canada to buy, sell, functional mushroom products

For hundreds of years, medicinal mushrooms have been revered among both ancient and modern cultures throughout the world for their nutritional and medicinal qualities. Pure Extract Technologies, a private plant-based Canadian extraction company headquartered in British Columbia, is leveraging the latest in science in its goal to become the leading extraction company engaged in the development and commercialization of functional and medicinal products.

Psychedelics appear to be going mainstream, as evidenced by the planned launch of the UC Berkeley Center for the Science of Psychedelics following an anonymous donation of $1.25 million for startup costs. Last studied over 50 years ago, UC Berkeley is once again opening the doors to psychedelic research with an aim to study the possible medical benefits of psychedelic drugs, specifically the chemical compound psilocybin found in “magic” mushrooms.

“There’s never been a better time to start a center like this,” said UC Berkeley neuroscientist and co-founder David Presti. “The renewal of basic and clinical science with psychedelics has catalyzed interest among many people.”

Psychedelic compounds are increasingly being researched for possible benefits that include anti-tumor effects, improved immune function, anti-viral properties, mental wellness benefits and detoxification. Specific neurochemical-related conditions of particular interest to leading academic and medical research institutions include depression, anxiety, PTSD, obesity, narcolepsy, bipolar disorder, Alzheimer’s, OCD, ADHD and drug and alcohol addiction.

Psychedelics were granted FDA breakthrough therapy status for treatment-resistant depression in 2020 with approvals expected in 2021.

Pure Extracts plans to obtain a Natural Health Products Site License from Health Canada to buy, sell and produce functional mushroom products in an EU-GMP-compliant environment, adequately positioning the Company to partner with organizations that plan to develop both functional and psychedelic products. Further solidifying the Company’s position on a global scale is its 10,000 square foot facility designed for EU-GMP certification that will enable sales throughout the world.

In addition to functional and medicinal products, Pure Extracts’ business model consists of three other verticals in connection with its existing cannabis and hemp extraction business. They include the marketing of in-house brands; toll processing – services in connection with the conversion of raw biomass into extracted oil products; and white labeling – the supply of products to existing brands looking to sell edibles, custom formulated oils and other cannabis-related products.

With a top spot among the fastest growing industries in North America, the mushroom industry is currently in a transitory phase whereby dry biomass is being converted to extracts. With a strong position in the industry, Pure Extracts is poised to benefit from this emerging trend as mushroom based products continue to enter mainstream awareness, bolstered by scientific research and ages-old therapeutic use.

For more information, visit the company’s website at www.PureExtractsCorp.com.

NOTE TO INVESTORS: The latest news and updates relating to Pure Extract Technologies are available in the company’s newsroom

About QualityStocks

QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT) Enters Updated LOI to Acquire 51% of Mobile Game Developer Csfctech

 Blue Hat Interactive Entertainment Technology (NASDAQ: BHAT), a leading producer, developer and operator of augmented reality (“AR”) interactive entertainment games, toys and educational materials in China, today announced its entry into an updated letter of intent (“LOI”). Under the terms of the LOI, BHAT will acquire the control of 51% of Fuzhou Csfctech Co. Ltd. (“Csfctech”) and its two subsidiaries through the direct acquisition of 51% of the outstanding shares of its offshore holding company. Csfctech is a developer and distributor of mobile games with an international user base across Mainland China, Japan, Taiwan, the United Arab Emirates and Africa. “We believe that this transaction represents a significant development in our strategy and ability to rollout a wider breath of augmented reality and mobile games to our growing audience in China,” BHAT CEO Xiaodong Chen said in the news release. “Csfctech’s business covers more than 100 games available on a number of different platforms and maintains a strong following of customers based in Asia and Africa. Through this acquisition, not only can we integrate the product development technology, operation and distribution resources of Csfctech, but also our combined resources may help strengthen the available distribution channels. In addition, we expect to leverage our combined expertise to improve the product structure and enhance the overall revenue scale and marketing capabilities.”

Click here to view the full press release

About Blue Hat

Blue Hat Interactive Entertainment Technology is a producer, developer and operator of AR interactive entertainment games and toys in China, including interactive educational materials, mobile games and toys with mobile-game features. The company’s entertainment platform creates unique user experiences by connecting physical items to mobile devices, which creates a rich visual and interactive environment for users through the integration of real objects and virtual scenery. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users. For more information, please visit the company’s investor relations website at www.IR.BlueHatGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Sugarmade Inc. (SGMD) Signs Agreement for Property to Use for Planned Cannabis Cultivation

 Sugarmade (SGMD) a leading, multidivisional/multiproduct/multisector supply company, has entered into a property lease agreement with LMK Capital LLC. The agreement includes five acres of cropland located in Northern California, which has been zoned for cannabis cultivation. Sugarmade plans to use the property to operate a licensed cannabis production business, which it anticipates may produce up to 3.6 million grams of high-quality cannabis flower annually. The company’s strategic plan calls for marketing the cannabis as both white-label and branded cannabis products through various distributors. Among those distributors will be BudCars Cannabis Delivery Service (“BudCars”), a cannabis delivery company that is seeing impressive growth. Sugarmade owns a 40% stake in BudCars, along with an option to acquire an additional 30%. “We believe we have all of the strategic pieces in place to capitalize on cultivation, with the market currently chronically undersupplied,” said Sugarmade chairman of the board, CEO, and CFO Jimmy Chan in the press release. “We also have relationships in place, especially through our BudCars investment, to hit the ground running on the branded products side, driving strong margins up and down the chain.”

To view the full press release, visit https://ibn.fm/NF3Uj

About Sugarmade Inc.

Sugarmade is a product and branding marketing company investing in operations and technologies with disruptive potential. The company’s brand portfolio includes CarryOutsupplies.com, SugarRush(TM) and Budcars.com. For more information, see the company’s website at www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Creatd Inc. (NASDAQ: CRTD) Appoints New COO to Lead Growth Strategy, Manage Partnership Initiatives

 Creatd (NASDAQ: CRTD, CRTDW), the parent company and creator of the Vocal platform, today announced the appointment of Laurie Weisberg as its new chief operating officer. Weisberg currently sits on Creatd’s board of directors and will lead the company’s sales team in the execution of its growth strategy and manage all strategic partnership initiatives. This appointment aligns with Creatd’s 2021 plans to broaden and scale its product line and revenues, including Vocal for Brands, Seller’s Choice, and Vocal+ paid subscriptions. “I have closely observed the Creatd team over the last year, particularly since I assumed my role as a member of the board of directors over the summer,” said Weisberg in the news release. “It is clear that the team’s ability to unleash the power of the network in delivering valuable content for audiences, while at the same time helping brands drive their growth by leveraging the highly engaged Vocal community and rich first-party data, makes Creatd a unique brand with a global proposition. As COO, I look forward to working closely with Jeremy and the rest of the management team to continue to build Creatd’s scalable and profitable business lines.”

To view the full press release, visit https://ibn.fm/GVOEZ

About Creatd Inc.

Creatd, the parent company and creator of the Vocal platform, empowers content creators and brands through technology and data-driven innovation. Creatd identifies opportunities within the digital platform and content monetization space, and leverages them through the company’s proprietary Vocal technology, as well as through complementary digital businesses including Vocal for Brands and Seller’s Choice. Since launching in 2016, Vocal has become home to over 700,000 content creators and brands of all shapes and sizes, attracting audiences across its network of wholly owned and operated communities. For more information about Creatd and its Vocal platform, visit www.Creatd.com and www.Vocal.media.

NOTE TO INVESTORS: The latest news and updates relating to CRTD are available in the company’s newsroom at http://ibn.fm/CRTD

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Closes Upsized NASDAQ Initial Public Offering

 Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF) (NASDAQ: SYTA, SYTAW), a leading global developer and provider of Push-to-Talk Over Cellular (“PTT/PoC”) systems for enterprise customers, has announced the closing of its upsized $12.6 million U.S. initial public offering on the NASDAQ. The company had previously announced the IPO of 2,100,000 units at a price of $6 per unit, with each unit comprised of one common share in the capital of the company and one warrant to purchase one common share in the capital of the company. The shares and warrants were issued separately and were approved to list on the Nasdaq Capital Market under the symbols “SYTA” and “SYTAW.” Trading began on Sept. 25, 2020, and at closing Siyata received gross proceeds of approximately $12.6 million before deducting underwriting discounts and commissions and other estimated expenses. The company has announced that it intends to use the net proceeds from the offering for sales and marketing, growth capital, research and development; any remainder would be used for working capital. Psagot Investment House, an Israeli investment firm and the country’s largest pension fund manager, was the lead investor in the offering.

To view the full press release, visit https://ibn.fm/E166C

About Siyata Mobile Inc.

Siyata Mobile is a B2B global vendor of next generation Push-To-Talk over Cellular (“PTT”) devices and cellular booster systems. Its portfolio of in-vehicle and rugged smartphones enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to improve communication, increase situational awareness and save lives.

Its portfolio of enterprise cellular booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for maximum cellular signal strength possible. For more information, visit the company’s websites at https://www.siyatamobile.com and http://unidencellular.com.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) CEO Addresses ‘Multi-Pronged Approach’ to Growing Problem of Workplace Stress and Anxiety

 VistaGen Therapeutics’ (NASDAQ: VTGN) CEO Shawn Singh authored a recent article for Business.com regarding the COVID-19 pandemic and resulting stress and anxiety impacts to the workplace. In the piece, Singh indicates that stress and anxiety, often driven by job-related issues, when left unchecked can rise to the level of an anxiety disorder with negative consequences for physical health, mental well-being, productivity and career opportunities. The global pandemic has exacerbated this largely unaddressed and widespread mental health problem in the workplace, markedly reflecting in increased prescriptions for antidepressant and anti-anxiety medications, many associated with significant side effects and safety concerns. “To adequately address the growing problem of workplace stress and anxiety both during and after the COVID-19 pandemic – and the physical and mental health consequences associated with it – a multi-pronged approach is needed,” states Singh in the article. “This approach should include the provision of additional mental/emotional health support from employers in the form of employee assistance programs (‘EAPs’), as well as novel approaches to psychotherapy and fundamentally different medications by mental health professionals.”

To view the full article, visit https://ibn.fm/XJCvn

About VistaGen Therapeutics

VistaGen is a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other CNS disorders where the current standard of care is inadequate, resulting in high unmet need. Each of VistaGen’s three drug candidates has a differentiated mechanism of action, an exceptional safety profile in all studies to date, and therapeutic potential in multiple CNS markets. For more information, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php

QualityStocksNewsBreaks – VistaGen Therapeutics (NASDAQ: VTGN) CEO Discusses PH94B Drug Candidate in Applied Clinical Trials Publication

 VistaGen Therapeutics (NASDAQ: VTGN), a biopharmaceutical company developing new generation medicines for anxiety, depression and other central nervous system (“CNS”) disorders, was recently featured in an Applied Clinical Trials article titled, “Pushing Late-Stage Treatments Forward in the Clinic.” In the article, VistaGen’s CEO Shawn Singh discussed the company’s ongoing efforts to treat and help manage the anxiety symptoms provoked by COVID-19 and other triggers, anxiety-related disorders initially in subjects suffering from Social Anxiety Disorder (“SAD”), as well as the FDA’s consensus on the design of the company’s pivotal Phase III study of PH94B. The piece quotes Singh, who states, “Now more than ever, patients around the world need new medications that go beyond the standard of care for anxiety, depression and suicidal ideation. For patients who have a debilitating mental health condition, our goal with PH94B for SAD, as well as for several other anxiety disorders, is to develop and offer an innovative, life-changing treatment that goes beyond the current standard of care and allows patients to manage their anxiety to the point where they are able to live their lives as the ideal version of themselves—a crucial driver for everything we do.”

To view the full article, visit https://ibn.fm/Ym21x

About VistaGen Therapeutics

VistaGen is a clinical-stage biopharmaceutical company developing new generation medicines for anxiety, depression and other CNS disorders where the current standard of care is inadequate, resulting in high unmet need. Each of VistaGen’s three drug candidates has a differentiated mechanism of action, an exceptional safety profile in all studies to date, and therapeutic potential in multiple CNS markets. For more information, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About QualityStocksNewsBreaks

QualityStocksNewsBreaks provide a rapid summary of corporate news that catch the attention of QualityStocks. QualityStocksBreaks are designed to keep investors up to date on important and breaking news in the small-cap and micro-cap markets. Spanning all industries, including energy, entertainment, telecommunications, healthcare, retail and more, these news breaks deliver opportunities the investment community may have missed. Whether it is earnings results, mergers and acquisitions, or any other market-moving news, our news breaks keep you in the know. QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential.

QualityStocks (QS)
Scottsdale, Arizona
www.QualityStocks.com
480.374.1336 Office
Editor@QualityStocks.com

Please see full terms of use and disclaimers on the QualityStocks website applicable to all content provided by QS, wherever published or re-republished: http://www.qualitystocks.net/disclaimer.php